Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease

Journal of Neuroscience

Volumn 21, Issue 20, 2001, Pages 8108-8118

  Åkerud, Peter ^a   Canals, Josep M ^a,d   Snyder, Evan Y ^b,c   Arenas, Ernest ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Dopaminergic neurons; GDNF; Glial cell line derived neurotrophic factor; Neuroregeneration; Neurotrophic factors; Striatum; Transplantation

Indexed keywords

GDNF C17.2; GENE PRODUCT; NEURITE PROMOTING FACTOR; NEUROPROTECTIVE AGENT; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL TYPE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; GENE EXPRESSION REGULATION; GENE THERAPY; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; SUBSTANTIA NIGRA;

EID: 0035887595     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-20-08108.2001     Document Type: Article

References (59)

1. Differential effects of GDNF and Neurturin on developing and adult substantia nigra dopaminergic neurons
2. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
3. Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat
4. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
5. Gene therapy of experimental brain tumors using neural progenitor cells
6. Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF
7. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
8. Cell replacement therapies for central nervous system disorders
9. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons
10. Adenovirus-mediated transgene expression in nonhuman primate brain
11. Thirty years of dopamine research
12. In vitro expansion of a multipotent population of human neural progenitor cells
13. Dopaminergic neurons protected from degeneration by GDNF gene therapy
14. Generation of tyrosine hydroxylase- producing neurons from precursors of the embryonic and adult forebrain
15. Prospects for new restorative and neuroprotective treatments in Parkinson's disease
16. Ageing and Parkinson's disease: Substantia nigra regional selectivity
17. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes
18. Mammalian neural stem cells
19. Functional recovery in parkinsonian monkeys treated with GDNF
20. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle
21. Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor
22. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: Possible neurochemical mechanisms
23. Understanding cell death in Parkinson's disease
24. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity
25. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
26. Long-term rAAV-mediated gene transfer of GDN F in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
27. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
28. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease
29. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
30. Simplified mammalian DNA isolation procedure
31. Efficient generation of midbrain and hindbrain neurons from mouse embrvonic stem cells
32. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
33. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms
34. Cerebral implantation in movement disorders: State of the art
35. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines
36. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats
37. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease
38. Immortalized neural progenitor cells for CNS gene transfer and repair
39. Rate of cell death in parkinsonism indicates active neuropathological process
40. Stem cells in the central nervous system
41. Efficient selection for high-expression transfectants with a novel eukaryotic vector
42. Etiology and pathogenesis of Parkinson's disease
43. Fetal nigral transplantation as a therapy for Parkinson's disease
44. Developing motor neurons rescued from programmed cell death by GDNF
45. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation
46. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
47. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion
48. Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions
49. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum
50. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex
51. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
52. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen
53. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
54. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons
55. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS
56. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes
57. Is there a neural stem cell in the mammalian forebrain?
58. Reversal of supersensitive apomorphine induced rotational behavior in mice by continuous exposure to apomorphine
59. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons